Chris Gibson
Angel
Overview
- Gender
- male
- Investor Type
- Angel
Chris Gibson is the Co-Founder and CEO of Recursion (Recursion Pharmaceuticals). He previously worked at Cure HHT as a Member Board of Directors. Chris Gibson attended the University of Utah.
Personal Investments
Number of Investments
2
Chris Gibson has made 2 investments. Their most recent investment was on
Aug 11, 2020, when Enveda Biosciences raised $4.90M.
| Date | Company Name | Round | Money Raised | Industry | |
|---|---|---|---|---|---|
| Jun 22, 2021 |
Enveda Biosciences
|
Series A | $51M | Biotechnology | Detail |
| Aug 11, 2020 |
Enveda Biosciences
|
Seed | $4.90M | Biotechnology | Detail |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
